We are thinking of you and your family during this unsettling time. In the midst of this extraordinary heartache and turmoil, cancer research to save lives gives us hope.

The Breastcancer.org team is dedicated to bringing you the most up-to-date breast cancer research news — no matter what. A few days ago, thousands of cancer experts from around the world gathered virtually for the annual American Society of Clinical Oncology (ASCO) meeting. The conference is an important opportunity to learn about breakthroughs in treatment, care, and technology. Our chief medical officer, Dr. Marisa Weiss, was among the experts presenting. Dr. Weiss shared Breastcancer.org's recent research on medical cannabis. Find out more about this study and other highlights we’re covering from #ASCO20 to empower and inform everyone impacted by breast cancer.

Breastcancer.org Study Finds 4 in 10 Breast Cancer Patients Have Used Cannabis to Treat Symptoms

Keytruda Plus Chemo More Beneficial Than Chemo Alone as First Treatment for Metastatic Triple-Negative Breast Cancer With High Levels of PD-L1

One Year of Low-Dose Xeloda After Surgery for Triple-Negative Breast Cancer May Reduce Recurrence Risk

Chemo Before Surgery for Early-Stage HER2-Positive Breast Cancer Doesn’t Have to Include Anthracycline

Experimental Pyrotinib + Xeloda Regimen Better Than Tykerb + Xeloda for Metastatic HER2-Positive Breast Cancer

Breastcancer.org | 120 East Lancaster Avenue, Suite 201 | Ardmore, PA 19003
Breastcancer.org is a nonprofit 501(c)(3) organization.